Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
BMC Cancer
|
October 9, 2012
Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test
Ralf Kronenwett, Kerstin Bohmann, Judith Prinzler, et al.
Oncoimmunology
|
October 3, 2024
Clinical prognosticators and targets in the immune microenvironment of intrahepatic cholangiocarcinoma
Isis Lozzi, Alexander Arnold, Matthias Barone, et al.
Journal of Proteome Research
|
November 11, 2011
Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling
Scarlet F Brockmöller, Elmar Bucher, Berit M Müller, et al.
Neoplasia (New York, N.Y.)
|
September 13, 2023
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer
Inga Hoffmann, Mihnea P Dragomir, Nanna Monjé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2012
RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy
C Denkert, S Loibl, R Kronenwett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2025
Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-Grade Serous Tubo-ovarian Cancer
Sofya Marchenko, Niklas Goernitz, Wiebke Alina Zoern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2023
RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial
Theresa Link, Jens-Uwe Blohmer, Wolfgang D Schmitt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 23, 2017
Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 years
Berit M Pfitzner, Bianca Lederer, Judith Lindner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2022
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer
Kim R M Blenman, Michal Marczyk, Thomas Karn, et al.
Human Pathology
|
September 24, 2023
LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinoma
Svenja Kolb, Inga Hoffmann, Nanna Monjé, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
BMC Cancer
|
October 9, 2012
Decentral gene expression analysis: analytical validation of the Endopredict genomic multianalyte breast cancer prognosis test
Ralf Kronenwett, Kerstin Bohmann, Judith Prinzler, et al.
Oncoimmunology
|
October 3, 2024
Clinical prognosticators and targets in the immune microenvironment of intrahepatic cholangiocarcinoma
Isis Lozzi, Alexander Arnold, Matthias Barone, et al.
Journal of Proteome Research
|
November 11, 2011
Integration of metabolomics and expression of glycerol-3-phosphate acyltransferase (GPAM) in breast cancer-link to patient survival, hormone receptor status, and metabolic profiling
Scarlet F Brockmöller, Elmar Bucher, Berit M Müller, et al.
Neoplasia (New York, N.Y.)
|
September 13, 2023
Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer
Inga Hoffmann, Mihnea P Dragomir, Nanna Monjé, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 8, 2012
RNA-based determination of ESR1 and HER2 expression and response to neoadjuvant chemotherapy
C Denkert, S Loibl, R Kronenwett, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 15, 2025
Transcriptome Analysis of Matched Cohorts of Long- and Short-term Survivors in Advanced High-Grade Serous Tubo-ovarian Cancer
Sofya Marchenko, Niklas Goernitz, Wiebke Alina Zoern, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2023
RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial
Theresa Link, Jens-Uwe Blohmer, Wolfgang D Schmitt, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
December 23, 2017
Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 years
Berit M Pfitzner, Bianca Lederer, Judith Lindner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2022
Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer
Kim R M Blenman, Michal Marczyk, Thomas Karn, et al.
Human Pathology
|
September 24, 2023
LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinoma
Svenja Kolb, Inga Hoffmann, Nanna Monjé, et al.
Page
of 6